EcoDrugPlus

Transient Receptor Potential Cation Channel Subfamily V Member 1

Ensembl ID : ENSUAMG00000028011
Gene Symbol: TRPV1
2 Cross references
134 Possible Orthologues:

Translocator Protein

Ensembl ID : ENSUAMG00000007734
Gene Symbol: TSPO
2 Cross references
126 Possible Orthologues:

Transthyretin

Ensembl ID : ENSUAMG00000002364
Gene Symbol: TTR
2 Cross references
164 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSUAMG00000009026
Gene Symbol: TUBA4A
2 Cross references
224 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSUAMG00000022001
Gene Symbol: TUBB1
2 Cross references
186 Possible Orthologues:

Tubulin Beta 2b Class Iib

Ensembl ID : ENSUAMG00000012630
Gene Symbol: TUBB2B
2 Cross references
181 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSUAMG00000015566
Gene Symbol: TUBB3
1 Cross references
144 Possible Orthologues:

Tubulin Beta 4a Class Iva

Ensembl ID : ENSUAMG00000023108
Gene Symbol: TUBB4A
2 Cross references
94 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSUAMG00000021502
Gene Symbol: TUBB4B
2 Cross references
316 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSUAMG00000021865
Gene Symbol: TUBB6
2 Cross references
140 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSUAMG00000026276
Gene Symbol: TUBB
2 Cross references
291 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSUAMG00000000730
Gene Symbol: TP53
2 Cross references
253 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).